NZCity NewsLinks -

All Links

4 Apr 2025

Search

EBOS Leadership Transition
EBOS Group Limited (“EBOS” or “the Group”) today announces that John Cullity will retire as Chief Executive Officer (CEO), effective 30 June 2025. EBOS is also pleased to announce that the Board has appointed Adam Hall as his succe

EBOS welcomes finalisation of First PWA
EBOS Group Limited (“EBOS”) advises that the First Pharmaceutical Wholesaler Agreement (the “Wholesaler Agreement”) has been signed by the Australian Government and the pharmaceutical wholesaler industry body, the National Pharmace

EBOS profits up thanks to boost in healthcare spending
Pharmaceutical supplier and animal products company EBOS has posted a solid lift in half-year profit.

Potential Ebos takeover called off after failed talks
Ebos has reportedly been in discussions with Australian pet care company Greencross over a potential deal, but discussions have concluded.

Chemist Warehouse to drop Ebos as supplier
Pharmaceutical supplier Ebos is to lose a major customer, potentially knocking a $2.1 billion hole in its earnings.

Julie Tay appointed as independent director
EBOS Group Limited (EBOS) is pleased to announce the appointment of Julie Tay as an independent director, effective 15 May 2023

EBOS annual revenue tops $11 billion for first time
Healthcare and animal care products company EBOS has posted double-digit profit growth.

EBOS - Advance Notice - Full Year Results
EBOS Group Limited will announce its full year financial results for the year ended 30 June 2022 on Wednesday, 24 August 2022

ACCC Announcement Regarding LifeHealthcare Acquisition
EBOS Group Limited (EBOS) notes the announcement by the Australian Competition and Consumer Commission (ACCC) today that it will not oppose the proposed acquisition of LifeHealthcare announced on 9 December 2021

Health and animal care products company EBOS posts another record half year profit
Revenue for the community pharmacy for the six months ending December was A$3.15 billion (NZ$3.4b)

EBOS posts lower profit after losing Chemist Warehouse contract
Despite the loss of the contract, chief executive John Cullity was "pleased" with the result, saying it was on track to meet its full-year underlying earnings guidance of $575-$600m.

Healthcare and animal products company EBOS posts strong profits
The chief executive out put the performance down growth in the community pharmacy and institutional healthcare divisions.

EBOS announces appointment of new Chief Financial Officer
EBOS Group Limited (“EBOS”) is pleased to announce the appointment of Alistair Gray to the role of Chief Financial Officer (“CFO”) with effect from 30 September 2024

EBOS increases its shareholding in Transmedic to 90%
EBOS Group Limited (EBOS) is pleased to announce that it has (via one of its wholly owned subsidiaries) increased its shareholding in Transmedic Pte Ltd (Transmedic) from 51% to 90%

EBOS annual revenue tops A$10 billion for first time
Underlying profit in the company's healthcare business increased by a third, and grew 24 percent in its animal care business.

Healthcare company EBOS posts record half-year profit
Chief executive John Cullity said it was driven by new acquisitions and growth in its healthcare division.

EBOS earnings rocket up 21pc to new record, lifts dividend
Medical supplies and animal healthcare company EBOS Group said strong first half growth was replicated in the second, driving underlying net profit up 21.3 per cent to a record A$228.2 million in the June year, its 100th year of operation.The...

EBOS advises that TerryWhite Chemmart network reaches 500 stores
EBOS Group Limited (“EBOS”) is pleased to advise that TerryWhite Chemmart (“TWC”) has celebrated the opening of its 500th network pharmacy. This milestone demonstrates the strength and momentum of the TWC franchise